Hamano Jun, Shima Yasuo, Kizawa Yoshiyuki
Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Department of Palliative Medicine, Tsukuba Medical Center Hospital, Tsukuba, Japan.
Ann Palliat Med. 2023 Jan;12(1):81-89. doi: 10.21037/apm-22-743.
Specialist palliative care for non-cancer patients is important; however, access to inpatient hospices/palliative care units (PCUs) for non-cancer patients in Japan may be insufficient. We aimed to explore the current situation, the support needs to accept admission of non-cancer patients, and the willingness to accept admission of non-cancer patients to inpatient hospices/PCUs in Japan.
We conducted a nationwide multicenter anonymous questionnaire survey to inpatient hospices/PCUs in Japan in January 2022. We recruited potential participants from 381 PCUs belonging to Hospice Palliative Care Japan (HPCJ).
A total of 264 of 381 facilities responded to the survey (response rate: 69.3%) and 75.0% replied that it was "very necessary" or "necessary" to provide health care coverage of hospitalization costs of non-cancer patients to the same level as cancer patients in inpatient hospices/PCUs. Furthermore, 59.1% replied that they would be "willing" or "somewhat willing" to admit non-cancer patients under the assumption that hospitalization costs covered by health care insurance. In addition, 15.2% of facilities had admitted non-cancer patients. A need for clarification of admission criteria for chronic heart failure (CHF) (rs =-0.166, P=0.008), chronic respiratory failure (rs =-0.146, P=0.019), chronic hepatic failure (rs =-0.161, P=0.010), and chronic renal failure (CRF) with dialysis (rs =-0.151, P=0.017); the need for an education and training system for chronic respiratory failure (rs =-0.132, P=0.034); and advice from experts in the hospital for chronic respiratory failure (rs =-0.156, P=0.013) were significantly negatively associated with willingness to accept the admission of non-cancer patients.
A total of 15.2% of facilities had admitted non-cancer patients under the current situation, and 59.1% of the facilities were willing to accept the admission of non-cancer patients under the assumption that hospitalization costs would be covered by health care insurance to the same level as cancer patients. Our study highlighted the importance of the establishment of a health insurance system in which appropriate palliative care is available regardless of disease, the definition of admission criteria, and the establishment of a systematic educational program.
为非癌症患者提供专科姑息治疗很重要;然而,在日本,非癌症患者入住住院临终关怀机构/姑息治疗病房(PCU)的机会可能不足。我们旨在探讨日本住院临终关怀机构/PCU的现状、接收非癌症患者入院所需的支持以及接收非癌症患者入院的意愿。
2022年1月,我们对日本的住院临终关怀机构/PCU进行了一项全国性多中心匿名问卷调查。我们从隶属于日本临终关怀与姑息治疗协会(HPCJ)的381个PCU中招募了潜在参与者。
381家机构中共有264家回复了调查(回复率:69.3%),75.0%的机构表示,在住院临终关怀机构/PCU中,为非癌症患者提供与癌症患者相同水平的住院费用医疗覆盖“非常必要”或“必要”。此外,59.1%的机构表示,在假设医疗保险覆盖住院费用的情况下,他们“愿意”或“有点愿意”接收非癌症患者。此外,15.2%的机构接收过非癌症患者。对慢性心力衰竭(CHF)(rs = -0.166,P = 0.008)、慢性呼吸衰竭(rs = -0.146,P = 0.019)、慢性肝衰竭(rs = -0.161,P = 0.010)和接受透析的慢性肾衰竭(CRF)(rs = -0.151,P = 0.017)入院标准的明确需求;对慢性呼吸衰竭教育和培训系统的需求(rs = -0.132,P = 0.034);以及医院慢性呼吸衰竭专家的建议(rs = -0.156,P = 0.013)与接收非癌症患者入院的意愿显著负相关。
在当前情况下,共有15.2%的机构接收过非癌症患者,59.1%的机构在假设住院费用将由医疗保险按与癌症患者相同水平覆盖的情况下愿意接收非癌症患者。我们的研究强调了建立一个无论疾病如何都能提供适当姑息治疗的医疗保险系统、明确入院标准以及建立系统教育项目的重要性。